T1	Person 0 4	Male
T2	Person 9 15	female
T3	Person 16 26	adolescent
*	OR T1 T2
T4	Person 37 41	aged
T5	Value 42 56	13 to 17 years
R1	Has_value Arg1:T4 Arg2:T5	
R2	Subsumes Arg1:T3 Arg2:T4	
T6	Condition 73 76	RLS
T7	Measurement 90 115	IRLSSG consensus criteria
R3	AND Arg1:T6 Arg2:T7	
T8	Measurement 147 171	Total RLS severity score
T9	Value 175 188	15 or greater
R4	Has_value Arg1:T8 Arg2:T9	
T10	Multiplier 295 338	at least 4 of 7 consecutive evenings/nights
T11	Condition 278 290	RLS symptoms
R5	Has_multiplier Arg1:T11 Arg2:T10	
T12	Measurement 369 380	Body weight
T13	Value 381 401	greater than 33.4 kg
R6	Has_value Arg1:T12 Arg2:T13	
T14	Measurement 439 454	body mass index
T15	Measurement 456 459	BMI
R7	Subsumes Arg1:T14 Arg2:T15	
T16	Value 467 486	5th-85th percentile
R8	Has_value Arg1:T14 Arg2:T16	
T17	Measurement 577 607	Estimated creatinine clearance
T18	Value 611 629	at least 60 mL/min
R9	Has_value Arg1:T17 Arg2:T18	
T19	Informed_consent 687 849	Signed patient and parent Institutional Review Board (IRB)-approved informed consent/assent form (as applicable) before any study-related procedures are performed
